ArticleScientific reports2025
Magnitude and determinants of adverse perinatal outcomes of pregnancies complicated with preeclampsia and eclampsia at a teaching hospital in the Tigray region of Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreeclampsia-eclampsia (PRE-E) syndrome remains a major global health issue because of its implications as an important cause of severe maternal and neonatal morbidity and mortality. Determining the magnitude of the problem and identifying factors that negatively affect outcomes is vital for clinical decision-making. Identifying high-risk pregnant women who need intensive observation and devising context-specific interventions to reduce unfavorable perinatal outcomes relies on understanding the magnitude and determinant factors. Hence, this study aimed to quantify the magnitude and determinant factors of adverse perinatal outcomes among pregnant women with preeclampsia-eclampsia syndrome at Ayder comprehensive specialized hospital in the Tigray region of Ethiopia.
methodsA cross-sectional study was conducted that included 934 pregnant women who had PRE-E syndrome at Ayder comprehensive specialized hospital from January 1, 2015, to December 31, 2021. Data were collected using EpiData (version 4.6.0.2) and analyzed using Stata version 16. A composite adverse perinatal outcome including fetal growth restriction, preterm birth, low Apgar score at the 5th minute, stillbirth, and neonatal death was calculated and used for analysis. Multivariable logistic regression was performed to identify determinant factors of adverse perinatal outcomes; results are described using adjusted odds ratio (AOR). A p-value less than 0.05 was used to declare a statistically significant difference.
resultsThe prevalence of adverse perinatal outcomes among the study participants was 65.1% (95% CI 61.2, 68.1). The overall perinatal mortality rate was 166 per 1000 live births. Multifetal gestation (AOR = 10.6, 95% CI 4.38, 25.69), primigravidity (AOR = 1.74, 95% CI 1.01,3.00), onset of PRE-E syndrome before 34 weeks (AOR = 29.75, 95% CI 12.8,68.7), and having severity features (AOR = 2.66, 95% CI 1.92,3.66) were significant determinants of adverse perinatal outcomes.
conclusionThe overall prevalence of adverse perinatal outcomes was consistent with countrywide findings and studies done elsewhere in low-resource settings. Early-onset preeclampsia, severe features, multifetal gestation, and primigravidity negatively affected perinatal outcomes. Thus, clinical profiles such as gravidity, gestational age at diagnosis, multifetal gestation, and severity features should be considered in clinical decision-making in low-resource settings. Perinatal outcomes may be improved through optimizing antepartum, intrapartum, and postpartum context- and gestational age-specific interventions, and adhering to established protocols with proven perinatal benefits such as administration of steroids, neuroprotection, and neonatal surfactant use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.